It takes nerves to fight infections: Insights on neuro-immune interactions from C. elegans

DMM Disease Models and Mechanisms

Volumn 3, Issue 11-12, 2010, Pages 721-731

  Kawli, Trupti ^a   He, Fanglian ^a   Tan, Man Wah ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ADRENALIN; ALCOHOL; GLUTAMIC ACID; NEUROPEPTIDE; NICOTINE; NORADRENALIN; SEROTONIN; TRANSCRIPTION FACTOR FOXO;

AGING; CAENORHABDITIS ELEGANS; DISEASE ASSOCIATION; DOPAMINERGIC ACTIVITY; EPITHELIUM CELL; HOMEOSTASIS; HUMAN; IMMUNOREGULATION; INFECTION; INNATE IMMUNITY; INTESTINE CELL; NEUROENDOCRINE SYSTEM; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CAENORHABDITIS ELEGANS; DISEASE MODELS, ANIMAL; EPITHELIUM; IMMUNITY, INNATE; INFECTION; NEUROIMMUNOMODULATION;

CAENORHABDITIS ELEGANS;

EID: 78649305874     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.003871     Document Type: Review

References (130)

1. Aballay, A. and Ausubel, F. M. (2001). Programmed cell death mediated by ced-3 and ced-4 protects Caenorhabditis elegans from Salmonella typhimurium-mediated killing. Proc. Natl. Acad. Sci. USA 98, 2735-2739.
2. Abdou, A. M., Higashiguchi, S., Horie, K., Kim, M., Hatta, H. and Yokogoshi, H. (2006). Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. Biofactors 26, 201-208. (Pubitemid 44359508)
3. Aberg, K. M., Radek, K. A., Choi, E. H., Kim, D. K., Demerjian, M., Hupe, M., Kerbleski, J., Gallo, R. L., Ganz, T., Mauro, T. et al. (2007). Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J. Clin. Invest. 117, 3339-3349.
4. Albertson, D. G. and Thomson, J. N. (1976). The pharynx of Caenorhabditis elegans. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 275, 299-325.
5. Alegado, R. A. and Tan, M. W. (2008). Resistance to antimicrobial peptides contributes to persistence of Salmonella typhimurium in the C. elegans intestine. Cell. Microbiol. 10, 1259-1273.
6. Alkema, M. J., Hunter-Ensor, M., Ringstad, N. and Horvitz, H. R. (2005). Tyramine Functions independently of octopamine in the Caenorhabditis elegans nervous system. Neuron 46, 247-260.
7. Alper, S., McBride, S. J., Lackford, B., Freedman, J. H. and Schwartz, D. A. (2007). Specificity and complexity of the Caenorhabditis elegans innate immune response. Mol. Cell. Biol. 27, 5544-5553.
8. Alverdy, J., Holbrook, C., Rocha, F., Seiden, L., Wu, R. L., Musch, M., Chang, E., Ohman, D. and Suh, S. (2000). Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: evidence for in vivo virulence expression in Pseudomonas aeruginosa. Ann. Surg. 232, 480-489.
9. Anyanful, A., Easley, K. A., Benian, G. M. and Kalman, D. (2009). Conditioning protects C. elegans from lethal effects of enteropathogenic E. coli by activating genes that regulate lifespan and innate immunity. Cell Host Microbe 5, 450-462.
10. Aravamudan, B., Fergestad, T., Davis, W. S., Rodesch, C. K. and Broadie, K. (1999). Drosophila UNC-13 is essential for synaptic transmission. Nat. Neurosci. 2, 965-971.
11. Arck, P. C., Slominski, A., Theoharides, T. C., Peters, E. M. and Paus, R. (2006). Neuroimmunology of stress: skin takes center stage. J. Invest. Dermatol. 126, 1697-1704. (Pubitemid 44086503)
12. Artal-Sanz, M., de Jong, L. and Tavernarakis, N. (2006). Caenorhabditis elegans: a versatile platform for drug discovery. Biotechnol. J. 1, 1405-1418.
13. Bargmann, C. I. (1998). Neurobiology of the Caenorhabditis elegans genome. Science 282, 2028-2033.
14. Bargmann, C. I. and Kaplan, J. M. (1998). Signal transduction in the Caenorhabditis elegans nervous system. Annu. Rev. Neurosci. 21, 279-308.
15. Basu, S. and Dasgupta, P. S. (2000). Dopamine, a neurotransmitter, influences the immune system. J. Neuroimmunol. 102, 113-124.
16. Ben-Yakar, A., Chronis, N. and Lu, H. (2009). Microfluidics for the analysis of behavior, nerve regeneration, and neural cell biology in C. elegans. Curr. Opin. Neurobiol. 19, 561-567.
17. Brogden, K. A., Guthmiller, J. M., Salzet, M. and Zasloff, M. (2005). The nervous system and innate immunity: the neuropeptide connection. Nat. Immunol. 6, 558-564.
18. Brose, N. and Rosenmund, C. (2002). Move over protein kinase C, you've got company: alternative cellular effectors of diacylglycerol and phorbol esters. J. Cell Sci. 115, 4399-4411.
19. Chase, D. L. and Koelle, M. R. (2007). Biogenic amine neurotransmitters in C. elegans. In WormBook (ed. The C. elegans Research Community). http://www.wormbook.org.
20. Cohen, S., Tyrrell, D. A. and Smith, A. P. (1991). Psychological stress and susceptibility to the common cold. N. Engl. J. Med. 325, 606-612.
21. Collins, J. J., Huang, C., Hughes, S. and Kornfeld, K. (2008). The measurement and analysis of age-related changes in Caenorhabditis elegans. In WormBook (ed. The C. elegans Research Community). http://www.wormbook.org.
22. Costa-Pinto, F. A. and Palermo-Neto, J. (2010). Neuroimmune interactions in stress. Neuroimmunomodulation 17, 196-199.
23. Couillault, C., Pujol, N., Reboul, J., Sabatier, L., Guichou, J. F., Kohara, Y. and Ewbank, J. J. (2004). TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM. Nat. Immunol. 5, 488-494. (Pubitemid 38660460)
24. Das, A. M., Flower, R. J. and Perretti, M. (1997). Eotaxin-induced eosinophil migration in the peritoneal cavity of ovalbumin-sensitized mice: mechanism of action. J. Immunol. 159, 1466-1473.
25. Dawidson, I., Blom, M., Lundeberg, T., Theodorsson, E. and Angmar-Mansson, B. (1997). Neuropeptides in the saliva of healthy subjects. Life Sci. 60, 269-278.
26. De la Fuente, M. (2008). Role of neuroimmunomodulation in aging. Neuroimmunomodulation 15, 213-223.
27. De Ley, P. (2006). A quick tour of nematode diversity and the backbone of nematode phylogeny. In WormBook (ed. The C. elegans Research Community). http://www.wormbook.org.
28. Dittman, J. (2009). Worm watching: imaging nervous system structure and function in Caenorhabditis elegans. Adv. Genet. 65, 39-78.
29. El Karim, I. A., Lamey, P. J., Ardill, J., Linden, G. J. and Lundy, F. T. (2006). Vasoactive intestinal polypeptide (VIP) and VPAC1 receptor in adult human dental pulp in relation to caries. Arch. Oral Biol. 51, 849-855.
30. El Karim, I. A., Linden, G. J., Orr, D. F. and Lundy, F. T. (2008). Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites. J. Neuroimmunol. 200, 11-16.
31. Elenkov, I. J., Wilder, R. L., Chrousos, G. P. and Vizi, E. S. (2000). The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52, 595-638.
32. Estes, K. A., Dunbar, T. L., Powell, J. R., Ausubel, F. M. and Troemel, E. R. (2010). bZIP transcription factor zip-2 mediates an early response to Pseudomonas aeruginosa infection in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 107, 2153-2158.
33. Evans, E. A., Kawli, T. and Tan, M.-W. (2008). Pseudomonas aeruginosa suppresses host immunity by activating the DAF-2 insulin-like signaling pathway in Caenorhabditis elegans. PLoS Pathog. 4, e1000175.
34. Feldman, S. and Weidenfeld, J. (1997). Hypothalamic mechanisms mediating glutamate effects on the hypothalamo-pituitary-adrenocortical axis. J. Neural Transm. 104, 633-642.
35. Feng, Z., Li, W., Ward, A., Piggott, B. J., Larkspur, E. R., Sternberg, P. W. and Xu, X. Z. (2006). A C. elegans model of nicotine-dependent behavior: regulation by TRPfamily channels. Cell 127, 621-633.
36. Garigan, D., Hsu, A. L., Fraser, A. G., Kamath, R. S., Ahringer, J. and Kenyon, C. (2002). Genetic analysis of tissue aging in Caenorhabditis elegans: a role for heatshock factor and bacterial proliferation. Genetics 161, 1101-1112.
37. Garsin, D. A., Villanueva, J. M., Begun, J., Kim, D. H., Sifri, C. D., Calderwood, S. B., Ruvkun, G. and Ausubel, F. M. (2003). Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens. Science 300, 1921.
38. Glaser, R. and Kiecolt-Glaser, J. K. (2005). Stress-induced immune dysfunction: Implications for health. Nat. Rev. Immunol. 5, 243-251.
39. Graff, J., Jemielity, S., Parker, J. D., Parker, K. M. and Keller, L. (2007). Differential gene expression between adult queens and workers in the ant Lasius niger. Mol. Ecol. 16, 675-683. (Pubitemid 46161088)
40. Graham, M. E., Edwards, M. R., Holden-Dye, L., Morgan, A., Burgoyne, R. D. and Barclay, J. W. (2009). UNC-18 modulates ethanol sensitivity in Caenorhabditis elegans. Mol. Biol. Cell 20, 43-55.
41. Gravato-Nobre, M. J. and Hodgkin, J. (2005). Caenorhabditis elegans as a model for innate immunity to pathogens. Cell. Microbiol. 7, 741-751.
42. Green, R. M., Gally, F., Keeney, J. G., Alper, S., Gao, B., Han, M., Martin, R. J., Weinberger, A. R., Case, S. R., Minor, M. N. et al. (2009). Impact of cigarette smoke exposure on innate immunity: a Caenorhabditis elegans model. PLoS ONE 4, e6860.
43. Greer, E. L. and Brunet, A. (2008). Signaling networks in aging. J. Cell Sci. 121, 407-412.
44. Guarente, L. and Kenyon, C. (2000). Genetic pathways that regulate ageing in model organisms. Nature 408, 255-262.
45. Haddad, J. J. (2004). Alcoholism and neuro-immune-endocrine interactions: physiochemical aspects. Biochem. Biophys. Res. Commun. 323, 361-371.
46. Hansen, C. J., Burnell, K. K. and Brogden, K. A. (2006). Antimicrobial activity of Substance P and Neuropeptide Y against laboratory strains of bacteria and oral microorganisms. J. Neuroimmunol. 177, 215-218.
47. Harbinder, S., Tavernarakis, N., Herndon, L. A., Kinnell, M., Xu, S. Q., Fire, A. and Driscoll, M. (1997). Genetically targeted cell disruption in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 94, 13128-13133.
48. Hein, L., Altman, J. D. and Kobilka, B. K. (1999). Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature 402, 181-184.
49. Hoebe, K., Janssen, E. and Beutler, B. (2004). The interface between innate and adaptive immunity. Nat. Immunol. 5, 971-974.
50. Horvitz, H. R., Chalfie, M., Trent, C., Sulston, J. E. and Evans, P. D. (1982). Serotonin and octopamine in the nematode Caenorhabditis elegans. Science 216, 1012-1014.
51. Irazoqui, J. E., Urbach, J. M. and Ausubel, F. M. (2010). Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates. Nat. Rev. Immunol. 10, 47-58.
52. Kang, L., He, Z., Xu, P., Fan, J., Betz, A., Brose, N. and Xu, T. (2006). Munc13-1 is required for the sustained release of insulin from pancreatic beta cells. Cell Metab. 3, 463-468. (Pubitemid 43811778)
53. Kapfhamer, D., Bettinger, J. C., Davies, A. G., Eastman, C. L., Smail, E. A., Heberlein, U. and McIntire, S. L. (2008). Loss of RAB-3/A in Caenorhabditis elegans and the mouse affects behavioral response to ethanol. Genes Brain Behav. 7, 669-676.
54. Kawli, T. and Tan, M.-W. (2008). Neuroendocrine signals modulate the innate immunity of Caenorhabditis elegans through insulin signaling. Nat. Immunol. 9, 1415-1424.
55. Kerry, S., TeKippe, M., Gaddis, N. C. and Aballay, A. (2006). GATA transcription factor required for immunity to bacterial and fungal pathogens. PLoS ONE 1, e77.
56. Kim, D. H., Feinbaum, R., Alloing, G., Emerson, F. E., Garsin, D. A., Inoue, H., Tanaka-Hino, M., Hisamoto, N., Matsumoto, K., Tan, M. W. et al. (2002). A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science 297, 623-626.
57. Kindt, K. S., Quast, K. B., Giles, A. C., De S., Hendrey, D., Nicastro, I., Rankin, C. H. and Schafer, W. R. (2007). Dopamine mediates context-dependent modulation of sensory plasticity in C. elegans. Neuron 55, 662-676.
58. King, T. E., Jr, Savici, D. and Campbell, P. A. (1988). Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages: smokers versus nonsmokers. J. Infect. Dis. 158, 1309-1316.
59. Kioussis, D. and Pachnis, V. (2009). Immune and nervous systems: more than just a superficial similarity? Immunity 31, 705-710.
60. Kudielka, B. M. and Wust, S. (2010). Human models in acute and chronic stress: assessing determinants of individual hypothalamus-pituitary-adrenal axis activity and reactivity. Stress 13, 1-14.
61. Kurz, C. L., Shapira, M., Chen, K., Baillie, D. L. and Tan, M.-W. (2007). Caenorhabditis elegans pgp-5 is involved in resistance to bacterial infection and heavy metal and its regulation requires TIR-1 and a p38 map kinase cascade. Biochem. Biophys. Res. Commun. 363, 438-443.
62. Li, C. (2005). The ever-expanding neuropeptide gene families in the nematode Caenorhabditis elegans. Parasitology 131, S109-S127.
63. Li, C. and Kim, K. (2008). Neuropeptides. In WormBook (ed. The C. elegans Research Community). http://www. wormbook. org.
64. Li, C., Nelson, L. S., Kim, K., Nathoo, A. and Hart, A. C. (1999). Neuropeptide gene families in the nematode Caenorhabditis elegans. Ann. NY Acad. Sci. 897, 239-252.
65. Linden, G. J., Mullally, B. H., Burden, D. J., Lamey, P. J., Shaw, C., Ardill, J. and Lundy, F. T. (2002). Changes in vasoactive intestinal peptide in gingival crevicular fluid in response to periodontal treatment. J. Clin. Periodontol. 29, 484-489.
66. Makara, G. B. and Stark, E. (1974). Effects of gamma-aminobutyric acid (GABA) and GABA antagonist drugs on ACTH release. Neuroendocrinology 16, 178-190.
67. Mallo, G. V., Kurz, C. L., Couillault, C., Pujol, N., Granjeaud, S., Kohara, Y. and Ewbank, J. J. (2002). Inducible antibacterial defense system in C. elegans. Curr. Biol. 12, 1209-1214. (Pubitemid 34801168)
68. Marutsuka, K., Nawa, Y., Asada, Y., Hara, S., Kitamura, K., Eto, T. and Sumiyoshi, A. (2001). Adrenomedullin and proadrenomudullin N-terminal 20 peptide (PAMP) are present in human colonic epithelia and exert an antimicrobial effect. Exp. Physiol. 86, 543-545.
69. McGhee, J. D. (2007). The C. elegans intestine. In WormBook (ed. The C. elegans Research Community). http://www.wormbook.org.
70. Mongan, N. P., Baylis, H. A., Adcock, C., Smith, G. R., Sansom, M. S. and Sattelle, D. B. (1998). An extensive and diverse gene family of nicotinic acetylcholine receptor alpha subunits in Caenorhabditis elegans. Recept. Channels 6, 213-228.
71. Mossner, R. and Lesch, K. P. (1998). Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav. Immunol. 12, 249-271. (Pubitemid 29224829)
72. Moy, T. I., Conery, A. L., Larkins-Ford, J., Wu, G., Mazitschek, R., Casadei, G., Lewis, K., Carpenter, A. E. and Ausubel, F. M. (2009). High-throughput screen for novel antimicrobials using a whole animal infection model. ACS Chem. Biol. 4, 527-533.
73. Muller, N., Ackenheil, M., Hofschuster, E., Mempel, W. and Eckstein, R. (1993). Cellular immunity, HLA-class I antigens, and family history of psychiatric disorder in endogenous psychoses. Psychiatry Res. 48, 201-217.
74. Murphy, C. T., McCarroll, S. A., Bargmann, C. I., Fraser, A., Kamath, R. S., Ahringer, J., Li, H. and Kenyon, C. (2003). Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424, 277-283.
75. Nandakumar, M. and Tan, M.-W. (2008). Gamma-linolenic and stearidonic acids are required for basal immunity in Caenorhabditis elegans through their effects on p38 MAP kinase activity. PLoS Genet. 4, e1000273.
76. Nathoo, A. N., Moeller, R. A., Westlund, B. A. and Hart, A. C. (2001). Identification of neuropeptide-like protein gene families in Caenorhabditis elegans and other species. Proc. Natl. Acad. Sci. USA 98, 14000-14005.
77. Nicholas, H. R. and Hodgkin, J. (2004). The ERK MAP kinase cascade mediates tail swelling and a protective response to rectal infection in C. elegans. Curr. Biol. 14, 1256-1261.
78. Nuorti, J. P., Butler, J. C., Farley, M. M., Harrison, L. H., McGeer, A., Kolczak, M. S., Breiman, R. F. and Active Bacterial Core Surveillance Team. (2000). Cigarette smoking and invasive pneumococcal disease. N. Engl. J. Med. 342, 681-689.
79. O'Neil, D. A., Porter, E. M., Elewaut, D., Anderson, G. M., Eckmann, L., Ganz, T. and Kagnoff, M. F. (1999). Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J. Immunol. 163, 6718-6724.
80. Obeid, P. and Bercy, P. (2000). Effects of smoking on periodontal health: a review. Adv. Ther. 17, 230-237.
81. Ooi, J. Y., Yagi, Y., Hu, X. and Ip, Y. T. (2002). The Drosophila Toll-9 activates a constitutive antimicrobial defense. EMBO Rep. 3, 82-87.
82. Peters, E. M., Ericson, M. E., Hosoi, J., Seiffert, K., Hordinsky, M. K., Ansel, J. C., Paus, R. and Scholzen, T. E. (2006). Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J. Invest. Dermatol. 126, 1937-1947.
83. Petrascheck, M., Ye, X. and Buck, L. B. (2007). An antidepressant that extends lifespan in adult Caenorhabditis elegans. Nature 450, 553-556.
84. Pierce, S. B., Costa, M., Wisotzkey, R., Devadhar, S., Homburger, S. A., Buchman, A. R., Ferguson, K. C., Heller, J., Platt, D. M., Pasquinelli, A. A. et al. (2001). Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes Dev. 15, 672-686. (Pubitemid 32244897)
85. Pujol, N., Zugasti, O., Wong, D., Couillault, C., Kurz, C. L., Schulenburg, H. and Ewbank, J. J. (2008a). Anti-fungal innate immunity in C. elegans is enhanced by evolutionary diversification of antimicrobial peptides. PLoS Pathog. 4, e1000105.
86. Pujol, N., Cypowyj, S., Ziegler, K., Millet, A., Astrain, A., Goncharov, A., Jin, Y., Chisholm, A. D. and Ewbank, J. J. (2008b). Distinct innate immune responses to infection and wounding in the C. elegans epidermis. Curr. Biol. 18, 481-489.
87. Raizen, D. M. and Avery, L. (1994). Electrical activity and behavior in the pharynx of Caenorhabditis elegans. Neuron 12, 483-495.
88. Rand, J. B. (2007). Acetylcholine. In WormBook (ed. The C. elegans Research Community). http://www.wormbook.org.
89. Reddy, K. C., Andersen, E. C., Kruglyak, L. and Kim, D. H. (2009). A polymorphism in npr-1 is a behavioral determinant of pathogen susceptibility in C. elegans. Science 323, 382-384.
90. Richmond, J. D. (2005). Synaptic function. In WormBook (ed. The C. elegans Research Community). http://www.wormbook.org.
91. Riddle, D. L., Blumenthal, T., Meyer, B. J. and Preiss, J. R. (1997). C. elegans II. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
92. Roeder, T., Seifert, M., Kahler, C. and Gewecke, M. (2003). Tyramine and octopamine: antagonistic modulators of behavior and metabolism. Arch. Insect Biochem. Physiol. 54, 1-13.
93. Rogers, C., Reale, V., Kim, K., Chatwin, H., Li, C., Evans, P. and de Bono, M. (2003). Inhibition of Caenorhabditis elegans social feeding by FMRFamide-related peptide activation of NPR-1. Nat. Neurosci. 6, 1178-1185.
94. Rosas-Ballina, M. and Tracey, K. J. (2009). Cholinergic control of inflammation. J. Intern. Med. 265, 663-679.
95. Sawin, E. R., Ranganathan, R. and Horvitz, H. R. (2000). C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway. Neuron 26, 619-631.
96. Schmidt, M. V., Scharf, S. H., Liebl, C., Harbich, D., Mayer, B., Holsboer, F. and Muller, M. B. (2010). A novel chronic social stress paradigm in female mice. Horm. Behav. 57, 415-420.
97. Schulenburg, H., Kurz, C. L. and Ewbank, J. J. (2004). Evolution of the innate immune system: the worm perspective. Immunol. Rev. 198, 36-58. (Pubitemid 38406934)
98. Shaked, I., Meerson, A., Wolf, Y., Avni, R., Greenberg, D., Gilboa-Geffen, A. and Soreq, H. (2009). MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity 31, 965-973.
99. Shapira, M. and Tan, M. W. (2008). Genetic analysis of Caenorhabditis elegans innate immunity. Methods Mol. Biol. 415, 429-442.
100. Shapira, M., Hamlin, B. J., Rong, J., Chen, K., Ronen, M. and Tan, M.-W. (2006). A conserved role for a GATA transcription factor in regulating epithelial innate immune responses. Proc. Natl. Acad. Sci. USA 103, 14086-14091. (Pubitemid 44452984)
101. Shimizu, M., Shigeri, Y., Tatsu, Y., Yoshikawa, S. and Yumoto, N. (1998). Enhancement of antimicrobial activity of neuropeptide Y by N-terminal truncation. Antimicrob. Agents Chemother. 42, 2745-2746.
102. Shirasu-Hiza, M. M., Dionne, M. S., Pham, L. N., Ayres, J. S. and Schneider, D. S. (2007). Interactions between circadian rhythm and immunity in Drosophila melanogaster. Curr. Biol. 17, R353-R355.
103. Shivers, R. P., Kooistra, T., Chu, S. W., Pagano, D. J. and Kim, D. H. (2009). Tissue-specific activities of an immune signaling module regulate physiological responses to pathogenic and nutritional bacteria in C. elegans. Cell Host Microbe 6, 321-330.
104. Sifri, C. D., Begun, J. and Ausubel, F. M. (2005). The worm has turned-microbial virulence modeled in Caenorhabditis elegans. Trends Microbiol. 13, 119-127.
105. Simon, D. J., Madison, J. M., Conery, A. L., Thompson-Peer, K. L., Soskis, M., Ruvkun, G. B., Kaplan, J. M. and Kim, J. K. (2008). The microRNA miR-1 regulates a MEF-2-dependent retrograde signal at neuromuscular junctions. Cell 133, 903-915.
106. Singh, S. P., Kalra, R., Puttfarcken, P., Kozak, A., Tesfaigzi, J. and Sopori, M. L. (2000). Acute and chronic nicotine exposures modulate the immune system through different pathways. Toxicol. Appl. Pharmacol. 164, 65-72.
107. Snoeks, L., Weber, C. R., Turner, J. R., Bhattacharyya, M., Wasland, K. and Savkovic, S. D. (2008). Tumor suppressor Foxo3a is involved in the regulation of lipopolysaccharide-induced interleukin-8 in intestinal HT-29 cells. Infect. Immunol. 76, 4677-4685.
108. Sopori, M. L., Kozak, W., Savage, S. M., Geng, Y., Soszynski, D., Kluger, M. J., Perryman, E. K. and Snow, G. E. (1998). Effect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms. Psychoneuroendocrinology 23, 189-204.
109. Sperandio, V., Torres, A. G., Jarvis, B., Nataro, J. P. and Kaper, J. B. (2003). Bacteria-host communication: the language of hormones. Proc. Natl. Acad. Sci. USA 100, 8951-8956.
110. Steinman, L. (2004). Elaborate interactions between the immune and nervous systems. Nat. Immunol. 5, 575-581. (Pubitemid 38811881)
111. Sternberg, E. M. (2006). Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat. Rev. Immunol. 6, 318-328.
112. Stone, A. A., Bovbjerg, D. H., Neale, J. M., Napoli, A., Valdimarsdottir, H., Cox, D., Hayden, F. G. and Gwaltney, J. M., Jr (1992). Development of common cold symptoms following experimental rhinovirus infection is related to prior stressful life events. Behav. Med. 18, 115-120.
113. Styer, K. L., Singh, V., Macosko, E., Steele, S. E., Bargmann, C. I. and Aballay, A. (2008). Innate immunity in Caenorhabditis elegans is regulated by neurons expressing NPR-1/GPCR. Science 322, 460-464.
114. Sulston, J. E. (1983). Neuronal cell lineages in the nematode Caenorhabditis elegans. Cold Spring Harbor Symp. Quant. Biol. 48, 443-452.
115. Sulston, J. E. and Horvitz, H. R. (1977). Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev. Biol. 56, 110-156.
116. Sulston, J. E. and White, J. G. (1980). Regulation and cell autonomy during postembryonic development of Caenorhabditis elegans. Dev. Biol. 78, 577-597.
117. Szabo, G. and Mandrekar, P. (2009). A recent perspective on alcohol, immunity, and host defense. Alcohol Clin. Exp. Res. 33, 220-232.
118. Tan, M.-W. (2001). Genetic and genomic dissection of host-pathogen interactions using a P. aeruginosa-C. elegans pathogenesis model. Pediatr. Pulmonol. 32, 96-97.
119. Tan, M. W., Mahajan-Miklos, S. and Ausubel, F. M. (1999). Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc. Natl. Acad. Sci. USA 96, 715-720.
120. Tatar, M., Bartke, A. and Antebi, A. (2003). The endocrine regulation of aging by insulin-like signals. Science 299, 1346-1351.
121. Troemel, E. R., Chu, S. W., Reinke, V., Lee, S. S., Ausubel, F. M. and Kim, D. H. (2006). p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genet. 2, 1725-1739.
122. Troemel, E. R., Felix, M. A., Whiteman, N. K., Barriere, A. and Ausubel, F. M. (2008). Microsporidia are natural intracellular parasites of the nematode Caenorhabditis elegans. PLoS Biol. 6, 2736-2752.
123. Wahl, S. M. (2007). Transforming growth factor-beta: innately bipolar. Curr. Opin. Immunol. 19, 55-62.
124. Wang, H., Yu, M., Ochani, M., Amella, C. A., Tanovic, M., Susarla, S., Li, J. H., Wang, H., Yang, H., Ulloa, L. et al. (2003). Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421, 384-388.
125. White, J. G., Southgate, E., Thomson, J. N. and Brenner, S. (1986). The Structure of the Nervous System of the Nematode Caenorhabditis elegans. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 314, 1-340.
126. Wrona, D. (2006). Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems. J. Neuroimmunol. 172, 38-58.
127. Zakharova, L. A. and Vasilenko, A. M. (2001). The opioidergic system in the combined regulation of pain and immunity. Biol. Bull. Russ. Acad. Sci. 28, 280-292.
128. Zhang, Y., Lu, H. and Bargmann, C. I. (2005). Pathogenic bacteria induce aversive olfactory learning in Caenorhabditis elegans. Nature 438, 179-184. (Pubitemid 41599864)
129. Zhao, C., Wang, I. and Lehrer, R. I. (1996). Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 396, 319-322. (Pubitemid 26377848)
130. Zugasti, O. and Ewbank, J. J. (2009). Neuroimmune regulation of antimicrobial peptide expression by a noncanonical TGF-beta signaling pathway in Caenorhabditis elegans epidermis. Nat. Immunol. 10, 249-256.